Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Glandular and Epithelial

Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.

12,665 public trials 2,916 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Glandular and Epithelial trial results

Recruiting

DBC-664 in Adult Patients With Solid Tumors

NCT07705035

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +14 more
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
  • START New York Lake Success, New York, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

NCT07291076

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Local Institution - 0137 Duarte, California, United States
  • Local Institution - 0070 Los Angeles, California, United States
  • Local Institution - 0107 Chicago, Illinois, United States
  • Local Institution - 0134 Detroit, Michigan, United States
View all 64 locations
View Trial Details
Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

APG-2449 in Patients With Advanced Solid Tumors

NCT03917043

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Cancer, +39 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

NCT07326566

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +19 more
Locations
  • University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Recruiting

Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma

NCT07699939

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +4 more
Locations
  • Chiba Cancer Center Chiba, Japan
  • Kyushu Cancer Center Fukuoka, Japan
  • Gifu University Hospital Gifu, Japan
  • Gunma University Hospital Maebashi, Gunma, Japan
View all 18 locations
View Trial Details
Recruiting

Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC

NCT07026474

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Klinikum Chemnitz gGmbH, Klinik für Radioonkologie Chemnitz, Germany
  • Klinikum Darmstadt GmbH, Institut für Radioonkologie und Strahlentherapie Darmstadt, Germany
  • Gemeinschaftspraxis Hämatologie-Onkologie Dresden Dresden, Germany
  • Helios Klinikum Erfurt, Klinik für Strahlentherapie Erfurt, Germany
View all 21 locations
View Trial Details

Related conditions